Clinical Decision Support software companies raised $1.2 billion in 43 venture funding rounds in 2020, compared to $748 million in 62 funding rounds in 2019,

Clinical Decision Support software companies raised $1.2 billion in 43 venture funding rounds in 2020, compared to $748 million in 62 funding rounds in 2019,
Tempus, an AI-powered precision medicine company, announced an additional $200 million financing at a post-money valuation of $8.1 billion. The investors include Baillie Gifford, Franklin
Top ten digital health funding deals accounted for 42% ($1.5 billion) of the total $3.6 billion raised in Q1 2020. One hundred thirty-two other digital
Tempus, a precision medicine company, raised $100 million in Series G financing round at a post-money valuation of $5 billion. Investors include: The investors include
Global VC funding for Digital Health companies in the first half of 2018 was 22 percent higher year-over-year (YoY) with a record $4.9 billion raised